Selling And Administration Expenses Cambiamento Data
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Amgen USD 1.76B 424M 2023-12
Avrobio USD 6.26M 1.68M 2023-09
BioCryst Pharmaceuticals USD 50.65M 349K 2023-09
Biogen USD 608.5M 179.7M 2023-12
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Bluebird Bio USD 40.7M 354K 2023-09
Capricor Therapeutics USD 3.02M 174.11K 2023-09
Daiichi Sankyo JPY 141.03B 4.45B 2023-09
Eli Lilly USD 1.92B 120.7M 2023-12
Esperion Therapeutics USD 33.24M 719K 2023-09
Gilead Sciences USD 1.61B 293M 2023-12
Incyte USD 293.86M 25.97M 2023-12
Insmed USD 89.53M 1.1M 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Lumos Pharma USD 3.89M 253K 2023-09
Moderna USD 470M 28M 2023-12
Nektar Therapeutics USD 21.15M 3.28M 2023-09
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Novavax USD 107.46M 25.24M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
PTC Therapeutics USD 76.29M 4.6M 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



Sarepta Therapeutics Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.